NCCAM Web Site User Satisfaction Survey

Thank you for visiting the NCCAM Web site.

Please help us improve our site by answering a few questions. This survey will take less than 5 minutes of your time. Your responses will be kept confidential and anonymous.

Would you like to take the online survey now?

To prevent this popup window from opening again during your current visit, your response will be stored in a temporary cookie. Review our privacy policy.

The Ginkgo Evaluation of Memory (GEM) Study

In a study published in the Journal of the American Medical Association, 240 milligrams per day of the dietary supplement Ginkgo biloba was found to be ineffective in reducing the development of dementia and Alzheimer's disease in older people. Researchers led by Steven T. DeKosky, M.D., conducted the trial known as the Ginkgo Evaluation of Memory (GEM) study at four clinical sites over the course of 8 years. GEM is the largest clinical trial ever to evaluate ginkgo's effect on the occurrence of dementia.

Press Release—summary of results of the study
Questions and Answers—detailed background information on the study

Related Resources

Ginkgo Herbs at a Glance Fact Sheet
Alzheimer's Disease Fact Sheet (National Institute on Aging)
Alzheimer's Disease (NIHSeniorhealth.gov)
Videos About Alzheimer's Disease (NIHSeniorhealth.gov)